Recent Updates
Recently added Catalysts
PIII Positive Sentiment

P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer

Key Takeaway: P3 Health Partners Inc. has appointed Dr. Michael Millie as Chief Clinical Officer, effective October 12, 2026. Dr. Millie brings extensive experience as a physician executive, having previously served as Chief Medical Officer. His appointment is expected to strengthen the company's focus on clinical and value-based care programs.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of an experienced physician executive.
  • Dr. Millie has a strong background in clinical care.
  • The move aims to enhance population health management.

Full Press Release Details

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the appointment of Dr. Michael Millie as Chief Clinical Officer, effective October 12, 2026. Dr. Millie is a proven physician executive who most recently served as a Chief Medical Officer, overseeing clinical and value-based care programs. A surgeon by training, he holds an MD from the University of Nebraska

Frequently Asked Questions

Who has been appointed as Chief Clinical Officer at P3 Health?

Dr. Michael Millie has been appointed as Chief Clinical Officer.

When does Dr. Millie's appointment take effect?

His appointment takes effect on October 12, 2026.

What is Dr. Millie's professional background?

Dr. Millie is a surgeon and has served as Chief Medical Officer.

What is the focus of P3 Health Partners?

P3 Health Partners focuses on patient-centered and physician-led population health management.

Last updated: Oct 12, 2026